Healthcare -
Biotechnology - NASDAQ - US
$ 1.67
-1.76 %
$ 15.5 M
Market Cap
-0.45
P/E
SABS - REVENUE
Revenue SABS - SAB Biotherapeutics, Inc.
1.32 M
LAST VALUE
-76.48%
2 YEAR CAGR
-17.41%
5 YEAR CAGR
0.00%
10 YEAR CAGR